S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
NYSE:JHB

Nuveen Corporate Income November 2021 Target Term Fund Stock Forecast, Price & News

$9.39
-0.01 (-0.11 %)
(As of 10/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.39
$9.40
50-Day Range
$9.37
$9.40
52-Week Range
$8.95
$9.44
Volume54,746 shs
Average Volume122,678 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield0.06%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive JHB News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuveen Corporate Income November 2021 Target Term Fund and its competitors with MarketBeat's FREE daily newsletter.


About Nuveen Corporate Income November 2021 Target Term Fund

Nuveen Corporate Income November 2021 Target Term Fund is a closed-end investment fund. The fund's objective is to provide a high level of current income. It invests in a portfolio of primarily below investment grade corporate debt securities. The company is headquartered in Chicago, IL.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Alternative Power Generation
Sub-Industry
N/A
Sector
Utilities
Phone
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.85 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Nuveen Corporate Income November 2021 Target Term Fund (NYSE:JHB) Frequently Asked Questions

What stocks does MarketBeat like better than Nuveen Corporate Income November 2021 Target Term Fund?

Wall Street analysts have given Nuveen Corporate Income November 2021 Target Term Fund a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Nuveen Corporate Income November 2021 Target Term Fund wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Nuveen Corporate Income November 2021 Target Term Fund?

Nuveen Corporate Income November 2021 Target Term Fund saw a increase in short interest in September. As of September 15th, there was short interest totaling 1,200 shares, an increase of 71.4% from the August 31st total of 700 shares. Based on an average daily volume of 114,500 shares, the short-interest ratio is presently 0.0 days.
View Nuveen Corporate Income November 2021 Target Term Fund's Short Interest
.

How has Nuveen Corporate Income November 2021 Target Term Fund's stock been impacted by Coronavirus (COVID-19)?

Nuveen Corporate Income November 2021 Target Term Fund's stock was trading at $9.55 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, JHB stock has decreased by 1.7% and is now trading at $9.39.
View which stocks have been most impacted by COVID-19
.

How often does Nuveen Corporate Income November 2021 Target Term Fund pay dividends? What is the dividend yield for Nuveen Corporate Income November 2021 Target Term Fund?

Nuveen Corporate Income November 2021 Target Term Fund announced a monthly dividend on Wednesday, September 1st. Stockholders of record on Wednesday, September 15th will be paid a dividend of $0.007 per share on Friday, October 1st. This represents a $0.08 annualized dividend and a dividend yield of 0.89%. The ex-dividend date of this dividend is Tuesday, September 14th.
View Nuveen Corporate Income November 2021 Target Term Fund's dividend history
.

Is Nuveen Corporate Income November 2021 Target Term Fund a good dividend stock?

Nuveen Corporate Income November 2021 Target Term Fund pays an annual dividend of $0.56 per share and currently has a dividend yield of 0.06%.
View Nuveen Corporate Income November 2021 Target Term Fund's dividend history.

Who are Nuveen Corporate Income November 2021 Target Term Fund's key executives?

Nuveen Corporate Income November 2021 Target Term Fund's management team includes the following people:
  • Walter M. Kelly, Chief Compliance Officer & Vice President
  • Gifford Ross Zimmerman, Secretary & Vice President
  • Stephen D. Foy, Vice President & Controller
  • Nathaniel T. Jones, Treasurer & Vice President
  • Cedric H. Antosiewicz, Chief Administrative Officer

Who are some of Nuveen Corporate Income November 2021 Target Term Fund's key competitors?

What other stocks do shareholders of Nuveen Corporate Income November 2021 Target Term Fund own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nuveen Corporate Income November 2021 Target Term Fund investors own include Omega Healthcare Investors (OHI), AGNC Investment (AGNC), Ares Capital (ARCC), NextEra Energy Partners (NEP), AT&T (T), B&G Foods (BGS), Carnival Co. & (CCL), Cisco Systems (CSCO), CVS Health (CVS) and 3D Systems (DDD).

What is Nuveen Corporate Income November 2021 Target Term Fund's stock symbol?

Nuveen Corporate Income November 2021 Target Term Fund trades on the New York Stock Exchange (NYSE) under the ticker symbol "JHB."

Who are Nuveen Corporate Income November 2021 Target Term Fund's major shareholders?

Nuveen Corporate Income November 2021 Target Term Fund's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Kestra Private Wealth Services LLC (0.00%) and Kestra Advisory Services LLC (0.00%).
View institutional ownership trends for Nuveen Corporate Income November 2021 Target Term Fund
.

Which major investors are selling Nuveen Corporate Income November 2021 Target Term Fund stock?

JHB stock was sold by a variety of institutional investors in the last quarter, including Kestra Private Wealth Services LLC, and Kestra Advisory Services LLC.
View insider buying and selling activity for Nuveen Corporate Income November 2021 Target Term Fund
or view top insider-selling stocks.

How do I buy shares of Nuveen Corporate Income November 2021 Target Term Fund?

Shares of JHB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nuveen Corporate Income November 2021 Target Term Fund's stock price today?

One share of JHB stock can currently be purchased for approximately $9.39.

What is Nuveen Corporate Income November 2021 Target Term Fund's official website?

The official website for Nuveen Corporate Income November 2021 Target Term Fund is www.nuveen.com.

Where are Nuveen Corporate Income November 2021 Target Term Fund's headquarters?

Nuveen Corporate Income November 2021 Target Term Fund is headquartered at 333 West Wacker Drive, Chicago, Illinois 60606.


This page was last updated on 10/23/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.